CognitoLite
Cranial phototherapy device
High power, 900 LEDs
Manufactured in UK
Self administered, just 6 minutes twice daily.
Free global shipping.
CognitoLite
Is protected by international Trademarks, Copyrights and Patents.
Do not discard in household waste.
This item can be recycled via the manufacturer.
Cranial phototherapy device
Apply twice daily for 6 minutes.
The CognitoLite is an LED phototherapy device that weighs 1.3Kg and is powered by a mains adapter.
It is worn twice daily for 6 minutes, and has an onboard timer and sensor electronics to detect if the device is functioning as intended.
No side effects were recorded during both published studies.
CognitoLite Trials
Parkinson's Study
Ongoing in USA, evaluating the efficacy of the CognitoLite helmet device on motor function in Parkinson's patients.
The preliminary results are encouraging, the research is ongoing.
Trials in UK
Pending approval, these trials are anticipated to commence towards the end of 2024
CognitoLite Technology
The CognitoLite was developed over the last decade and is the culmination of two decades of research by Durham University.
The initial development was identifying the unique wavelength range which is therapeutic. The laboratory studies indicated the wavelengths between 1060 nm and 1075 nm had the most therapeutic effect. Laboratory studies also identified wavelengths in the NIR that should be avoided.
Optical power density was evaluated before helmet design was optimised. Intrinsically safe light sources were used in the design, LEDs, but the high optical power density requirement required the design of a high density LED helmet which did not become too warm and could fit on a human head of any size and shape. The current CognitoLite design satisfies the necessary criteria, utilising almost the entire area of the cranium for application of the NIR light.